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Retinoids, compounds exhibiting diverse biological activities, are
associated with immunological activation, vision, differentiation
and cancer growth control. Their effects on gene expression are
mediated through binding with nuclear retinoic acid receptor
(RAR) and retinoid x receptor (RXR) (Mangelsdorf et al, 1994;
Leblanc and Strunnenberg, 1995). Three subtypes of RAR and
RXR (a, band g) and multiple isoforms within each subtype of
receptor have been identified. Each receptor subtype exhibits
distinct functions, which is supported by their specific patterns of
expression in the developing mouse embryo as well as unique
distributions in adult tissues (Mangelsdorf et al, 1994). Both RAR
and RXR share high sequence homology in the DNA and ligand-
binding domains. RARs bind all-transretinoic acid (RA) and 9-cis
RA with high affinity; whereas RXRs bind with high affinity only
with the 9-cisRA (Heyman et al, 1992). RA-mediated regulation
of gene expression is primarily acted through the formation of
RAR/RXR heterodimers that bind with high affinity to the DNA
sequence known as the retinoic acid response element. In addition
to forming heterodimers with RAR, RXR can also form homo-
dimers, in the presence of 9-cisRA, or heterodimers with thyroid
hormone receptor, vitamin D receptor or orphan receptors
(Mangelsdorf et al, 1994; Leblanc and Strunnenberg, 1995).
The nuclear receptors appear to be the prominent mediators of
RA action on gene expression. Therefore, it is of interest to deter-
mine whether their levels are altered during cancer development
and whether their expression patterns in premalignant and malig-
nant tissues can provide prognostic information. Cancer cell lines
are found to have lost or have alterations in RARbexpression (Hu
et al, 1991; Shyu et al, 1995). In addition, the introduction of
RARbinto cells which do not express RARbleads to suppression
of tumorigenesis in vivo (Houle et al, 1993; Kaiser et al, 1997).
These results suggest that RARbmay function as a tumour
suppressor. The frequent loss of RARbexpression in cancer
tissues from the head and neck, lung and breast supports this
conclusion (Xu et al, 1994a, 1997a, 1997b; Widschwendter et al,
1997). Down-regulation of RARawas observed in chemical-
induced as well as H-ras-transformed mouse skin tumours
(Darwiche et al, 1995, 1996) and squamous head and neck
tumours (Issing and Wustrew, 1996). Decreased RARgexpression
was observed in mouse skin tumours (Darwiche et al, 1995, 1996)
and non-small-cell lung tumours (Xu et al, 1997a). In addition,
RXRawas found to decrease in mouse skin tumours (Darwiche et
al, 1995) and RXRbwas found to increase in non-small-cell lung
tumours (Xu et al, 1997a). These results suggest each subtype of
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hybridization to investigate expression of retinoic acid receptors (RARs) and retinoid x receptors (RXRs) in premalignant and malignant
formalin-fixed paraffin-embedded gastric tissues. Histological sections of eight normal, 17 distal normal and nine gastric cancer tissues were
hybridized with non-radioactive RNA probes for subtypes of RAR and RXR. Expression of RARa, RARb, RARg, RXRaand RXRbwas found
in most cell types in gastric mucosa tissues from normal individuals as well as in distal normal tissues from cancer patients. Expression of
RARaand RARbwere found in three and seven cancer tissues, respectively, and levels of RXRamRNA were significantly decreased in
poorly differentiated cancer tissues. Among the five investigated nuclear retinoid receptors, only expression of RARamRNA was significantly
decreased in intestinal metaplasia, dysplasia and cancer tissues when compared to adjacent normal tissues. In conclusion, normal gastric
mucosa expressed both RARs and RXRs, which supports the physiological role of retinoic acid on normal gastric mucosa. The decrease in
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Republic of Chinanuclear retinoid receptor may be altered distinctly in different
tissues during carcinogenesis. This is further evidence that each
receptor subtype has a unique function in different tissues.
The role of retinoids in gastric cancer treatment and prevention
has been studied previously. Epidemiological and animal studies
have demonstrated the activities of retinoids in prevention
(Haenszel et al, 1985; Miasoedov et al, 1989) and treatment (Fujii
et al, 1991) of gastric cancer. These studies support our recent
observation of the growth suppressive activity of all trans RA and
13-cis RA on gastric cancer cells in vitro and in vivo (Shyu et al,
1995; Jiang et al, 1996). To further understand the roles of nuclear
retinoid receptors in gastric mucosa, we have used an in situ
hybridization method to detect expression of subtypes of RAR
and RXR in histological sections of formalin-fixed, paraffin-
embedded gastric tissues from normal individuals and gastric
cancer patients.
MATERIALS AND METHODS
Specimen collection and preparation
Four pairs of biopsy specimens from the gastric body and antrum
regions of normal individuals undergoing health check-ups were
obtained using a pandoscope. In addition, nine gastric cancer
tissues and 17 distal normal tissues (eight from the body and nine
from the antrum regions) from nine patients were obtained by
pandoscope. Tissues were fixed in 10% neutral formalin and
embedded in paraffin. The specimens were sliced into 4-mm-thick
sections. Haematoxylin and eosin (H&E)-stained tissue sections
were screened by the same pathologist to identify adjacent normal
tissues, intestinal metaplasia, dysplasia and carcinoma. Gastric
cancer tissues were classified based on the criteria of World Health
Organization (Watanabe et al, 1989).
Subcloning of RAR and RXR cDNA
The 1.9 kb of human RARa (Petkovich et al, 1987), 1.9 kb of
human RXRa (Mangelsdorf et al, 1990) and 2.2 kb of human
RXRb (Hamada et al, 1989) cDNA fragments were cloned into the
Eco RI site of the plasmid pBSK+/– (Stratagene, La Jolla, CA, USA)
through blunt end ligation. The 1.6 kb of human RARb (Brand et al,
1988) and 1.7 kb of human RARg (Zelent et al, 1989) cDNA frag-
ments were cloned into the Not I site of the plasmid pRC/CMV
(Invitrogene Co., San Diego, CA, USA) through blunt end ligation.
Preparation of digoxigenin-labelled RNA probes
The digoxigenin-labelled RNA probes spanning the entire open-
reading frames of cDNAs of RARa, RARb, RARg, RXRa or
RXRb cDNA were synthesized using an in vitro transcription kit
obtained from Boehringer Mannheim (Germany) (Xu et al,
1994b). The RNA probes were precipitated, washed and dissolved
in diethylpyrocarbonate-treated water containing RNAsin. The
concentration was adjusted to 100 ng ml-1 using a DNA Dipstick
Kit (Invitrogene) and stored at –70°C. The length of the RNA
probes was confirmed by RNA gel electrophoresis followed by
visualization using the fluorescence substrate CSPD as described
below. The specificity of the probes was determined by Northern
blotting.
RNA isolation and Northern blotting
SC-M1 and TSGH9201 human gastric cancer cell lines cells were
grown in T75 cm2 flasks in RPMI-1640 medium supplemented
with 5% fetal bovine serum and antibiotics in a humidified atmos-
phere of 5% carbon dioxide and 95% air at 37°C. Polyadenosine
(poly-A)+ RNA was purified from cellular lysates using oligo dT
cellulose as described by Badley and co-workers (Badley et al,
1987). RNA was then fractionated on a 1.1% agarose, 1.1%
formaldehyde gel in 5 mM NaOAc, 1 mM EDTA, 20 mM 3-[N-
morpholino]propanesulphonic acid, pH 7.0 and transferred to a
nylon membrane (Boehringer Mannheim) by capillary blotting in
20 ´ saline–sodium citrate (SSC; 3 M NaCl, 0.3 M Na3 citrate,
pH 7.0). Blots were UV-fixed, prehybridized and hybridized at
68°C in buffer containing 50% (v/v) formamide, 5 ´ SSC, 2%
(w/v) blocking reagent (Boehringer Mannheim), 0.1% N-lauroyl-
sarcosine and 0.2% (w/v) sodium dodecyl sulphate (SDS). The
membranes were washed first with 2 ´ SSC containing 0.1%
SDS and then washed with 0.1 ´ SSC containing 0.1% SDS at
68°C for 30 min. Specific hybridization was detected by a DIG
luminescence detection kit using CSPD as the substrate and
was recorded using Kodak XAR-5 film at room temperature.
Probes were removed and membranes were then hybridized with
the digoxigenin-labelled probe for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH).
In situ hybridization
A nonradioactive in situ hybridization using digoxigenin-labelled
riboprobes was used as described by Xu and co-workers (Xu et al,
1994b). Briefly, sections were deparaffinized, rehydrated and
deproteinized by digestion with protease K. The slides were fixed
with 4% paraformaldehyde and then acetylated in 0.25% acetic
anhydride in 0.1 M triethanolamine-HCl buffer. After washing and
dehydration, the slides were prehybridized for more than 1 h at
42°C with a hybridization solution containing 50% deionized
formamide, 2 ´ SSC, 2 ´ Denhardt’s solution (0.02% Ficoll 400,
0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin), 10%
dextran sulphate, 400 mg ml-1 yeast tRNA, 250 mg ml-1 salmon
sperm DNA and 20 mM dithiothreitol in diethylpyrocarbonate-
treated water. Then, the slides were incubated with a 50 ml per
slide hybridization solution containing 100 ng freshly denatured
digoxigenin-labelled RNA probes at 42°C for 16 h in closed
humid containers. After incubating with RNase A, the slides were
washed and then blocked for non-specific binding using 2%
normal sheep serum. The slides were incubated overnight at 4°C
with sheep anti-digoxigenin antibody, and the in situ hybridization
signal was visualized by incubating the slides in a chromogen
solution containing nitroblue tetrazolium and X-phosphate
(Boehringer Mannheim). Slides were observed under an AH-1
light microscope (Olympus, Japan) and then stored dark at 4°C.
Reviewing and scoring the sections
All sections from the same patient were stained on the same day
with the same reagents to ensure a proper comparison of the
different sections. The sections were reviewed by three indepen-
dent researchers, including a pathologist. The staining of the
sections was assigned scores ranging from 0 to 4, representing no
staining (0), weak (1 +), positive (2 +), strongly positive (3 +), or
very strongly positive (4 +). The intensity of staining in the surface
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mucus cells, mucus neck cells, parietal cells and chief cells was
analysed in the body tissues. The intensity of staining in the
surface mucus cells and regenerative and mature gland cells in the
antrum tissues was analysed. Correlation of RXRa and RXRb
expression between cancer tissues with poor vs non-poor differen-
tiation was analysed by Fisher’s Exact Test. Differential expres-
sion of RARa mRNA in adjacent normal, intestinal metaplasia
adjacent to gastric cancer, dysplasia adjacent to gastric cancer and
gastric cancer tissues from different or the same gastric cancer
patients was analysed by logistic regression. However, the estimated
coefficients and their correspondent variances were obtained
through the generalized estimating equations method (Liang and
Zeger, 1986) and the SAS/IML macro program, GEE1.SAS, to
take into account the within subject correlation.
RESULTS
Activity and specificity of digoxigenin-labelled RNA
probes
The activity of digoxigenin-labelled probes was first tested by
Northern hybridization on gastric cancer cells. Antisense RNA
probes of each RAR or RXR subtype could detect specific mRNA
subtypes of RAR and RXR (Figure 1). The molecular weights of
each subtype of RAR or RXR mRNA transcript in SC-M1 or
TSGH9201 gastric cancer cells detected were similar to results
described previously (Shyu et al, 1995). Therefore, the binding of
antisense RNA probes was specific. No band was shown in the
mRNA samples hybridized with five control sense RNA probes.
Staining of RAR and RXR mRNA in tissues
Expression of the mRNAs for RAR and RXRs in gastric cancer
tissues was analysed by non-radioactive in situ hybridization.
Figure 2 shows the mRNA localization of RARa, RARb, RARg,
RXRa and RXRb in consecutive sections of a specimen from the
body region with moderately differentiated gastric cancer by
digoxigenin-labelled RNA probes. Positive results appeared as a
dark purple colour in the cytoplasm, where mRNA is expected to
be localized. The adjacent normal gland had the highest expression
of RXRa mRNA and the lowest expression of RARb mRNA (see
below). The sense probes did not bind to the adjacent sections,
indicating that hybridization with the antisense probes was
specific.
Expression of RARs and RXRs in non-malignant gastric
body and antrum tissues
Four pairs of body and antrum tissues from individuals without
cancer were analysed for in situ expression of nuclear retinoid
receptor mRNAs. H&E staining showed that three specimens
exhibited features of gastritis and one exhibited atrophic gastritis
in both antrum and body tissues. In addition to gastritis, intestinal
metaplasia and dysplasia were also found in two antrum tissues.
Expression of RAR and RXR mRNAs in areas without intestinal
metaplasia and dysplasia was analysed.
Expression of mRNAs of nuclear retinoid receptors in surface
mucus, mucus neck, parietal and chief cells was analysed in speci-
mens derived from the body tissues. In the antrum tissues, expres-
sion of nuclear retinoid receptors in surface mucus, regenerative
gland and mature gland cells was analysed. Most cell types
analysed from both body and antrum tissues expressed five
subtypes of nuclear retinoid receptors (data not shown). No cell
type-specific expression of a unique subtype of RAR or RXR was
observed. However, mRNA of RXRa was found to express at
levels equivalent to or higher than that of the other four tested
nuclear retinoid receptors in all analysed cell types. Also, RARa
mRNA appeared to be more abundant than RARb or RARg in
some specimens. Similar results were obtained in eight distal
normal body and nine distal normal antrum tissues from patients
with gastric cancer.
Expression of RARs and RXRs in gastric cancer
tissues
Nine gastric cancer specimens, four derived from the body region
and five derived from the antrum region, were analysed. All
tissues exhibited the morphology of adenocarcinoma. Two speci-
mens exhibited the morphology of both tubular and papillary
tumours. Four specimens were the tubular type and three were the
signet-ring cell type (Table 1). Among nine investigated cancer
tissues, RARg, RXRa and RXRb were expressed in all nine, while
RARa and RARb were expressed in three and seven cancer tissues
respectively. Among tissues found to express RARa, two were
well-differentiated and one was moderately differentiated. Both
papillary and tubular types of adenocarcinoma cells were found to
stain positively for RARa mRNA in the two cancer tissues that
exhibited the morphology of both. None of two cancer tissues with
poor differentiation expressed RARa. Among six tissues without
RARa expression, three exhibited the morphology of tubular type
and the other three were the signet-ring cell type tumours. Well
and moderately differentiated gastric adenocarcinoma expressed
higher levels of RXRa mRNA than the poorly differentiated
adenocarcinoma, and the difference was significant (P = 0.03). A
similar trend, although not a significant difference (P = 0.083),
was observed for RXRb.
Differential expression of RARs and RXRs in distal
normal tissues, intestinal metaplasia adjacent to
gastric cancer, and dysplasia adjacent to gastric cancer
tissues from different gastric cancer patients
Adjacent normal tissues, intestinal metaplasia, dysplasia and
cancer tissues from the same tissue section of different gastric
cancer patients were compared. Most of the gastric cancer cells
were believed to be derived from neck cells which exhibited
S AS S AS S AS S AS S AS
GAPDH
RARa RARb RARg RXRa RXRb
Figure 1 Northern blot analysis of RAR and RXR in gastric cancer cells.
mRNA from SC-M1 cells was hybridized with sense (S) or antisense (AS)
RNA probes for RARa, RARg, RXRa or RXRb. mRNA from TSGH9201 cells
was hybridized with RARb sense and antisense RNA probes. Probes were
removed and the same membranes were then hybridized with a GAPDH
probeRAR and RXR expression in gastric tissues 209
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Figure 2 Detection of subtypes of RAR and RXR mRNA expression in a gastric cancer tissue with moderately differentiated adenocarcinoma from the body
region using RNA probes. Tissues were hybridized with antisense (A, C, E, G and I) or sense (B, D, F, H and J) probes for RARa (A and B), RARb (C and D),
RARg (E and F), RXRa (G and H) and RXRb (I and J) respectively. (K) H&E staining. Magnification 100 ´; N, adjacent normal tissues; C, cancer tissues210 S-Y Jiang et al
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Figure 3 Detection of subtypes of RAR and RXR mRNA expression in a gastric cancer tissue with well-differentiated adenocarcinoma from the antrum region
using RNA probes. Tissues were hybridized with antisense (A, C, E, G and I) or sense (B, D, F, H and J probes for RARa (A and B), RARb (C and D), RARg (E
and F), RXRa (G and H) and RxRb (I and J) respectively. (K) H&E staining. The adjacent normal tissues (N) are shown on the left of each panel and cancer
lesions (C) are shown on the right. Magnification ´ 200RAR and RXR expression in gastric tissues 211
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Table 1 Expression of mRNA of nuclear retinoid receptors in gastric cancer tissues
Case Differentiation Histological RARa RARb RARg RXRa RXRb
no. types
1 Well Tubular + papillary +* ++ +++ ++++ ++
2 Well Tubular + papillary + ++ ++ ++++ ++
3 Well Tubular – + ++ +++ ++
4 Moderate Tubular ++ ++ +++ +++ +++
5 Moderate Signet-ring cell – – ++ +++ +++
6 Moderate Tubular – – ++ +++ +
7 Moderate Tubular – ++ + ++++ ++
8 Poor Signet-ring cell – + + ++ +
9 Poor Signet-ring cell – + ++ ++ +
aIntensity of staining. –, no staining; +, weak staining; ++, positive staining; +++, strongly positive staining, ++++, very strongly positive staining.
Table 2 Differential expression of RARs and RXRs in distal normal, adjacent normal, intestinal metaplasia adjacent to gastric cancer
and dysplasia adjacent to gastric cancer from different gastric cancer patients
% Positivea (No. positive/total)
Receptors
Distal normalb Adjacent normalb IMc Dysplasia Cancer
RARa 100 (17/17) 88 (7/8)d,e,f 43 (3/7)d 38 (3/8)e 25 (2/8)f
RARb 100 (17/17) 88 (7/8) 86 (6/7) 88 (7/8) 88 (7/8)
RARg 100 (17/17) 100 (8/8) 100 (7/7) 100 (8/8) 100 (8/8)
RXRa 100 (17/17) 100 (8/8) 100 (7/7) 100 (8/8) 100 (8/8)
RXRb 100 (17/17) 100 (8/8) 100 (7/7) 100 (8/8) 100 (8/8)
aPositive cases were those stained with an intensity score of > 1. bIntensity of staining in mucous neck cells or regenerative antrum gland
cells. cIntestinal metaplasia. dP < 0.05; odds ratio (OR) = 0.11; 95% confidence interval (CI), (0.01, 0.88). eP < 0.05; OR = 0.09;
95% CI, (0.01, 0.75). fP < 0.05; OR = 0.05; 95% CI, (0.00, 0.50).
Table 3 Expression of RARs and RXRs in adjacent normal tissues, intestinal metaplasia, dysplasia and cancer lesions from the same
gastric cancer patient
No. of cases (% of total)
Receptors No. of cases AT > Cb AT = Cc AT < Cd
Comparison of cancer and
adjacent normal tissuesa
RARa 8 7 (88)e,f 1 (12) 0 (0)
RARb 8 0 (0) 8 (100) 0 (0)
RARg 8 2 (15) 6 (75) 0 (0)
RxRa 8 0 (0) 8 (100) 0 (0)
RxRb 8 3 (37) 5 (63) 0 (0)
Comparison of cancer and
intestinal metaplasia tissues
RARa 7 2 (29)e 4 (57) 1 (14)
RARb 7 0 (0) 7 (100) 0 (0)
RARg 7 0 (0) 7 (100) 0 (0)
RxRa 7 0 (0) 7 (100) 0 (0)
RxRb 7 1 (14) 5 (72) 1 (14)
Comparison of cancer and
adjacent dysplasia tissues
RARa 8 2 (25)f 5 (63) 1 (12)
RARb 8 0 (0) 8 (100) 0 (0)
RARg 8 0 (0) 8 (100) 0 (0)
RxRa 8 0 (0) 8 (100) 0 (0)
RxRb 8 1 (13) 7 (88) 0 (0)
aCompared with adjacent mucus neck cells in body tissues or adjacent regenerative gland in antrum tissues. bA > C: expression of
mRNA was greater in adjacent tissues (AT) than in cancer (C). cA = C: expression of mRNA was similar in adjacent tissues (AT) than in
cancer (C). dA < C: expression of mRNA was lower in adjacent tissues (AT) than in cancer (C). eP < 0.05; odds ratio (OR) = 0.06; 95%
confidence Interval (CI), (0.01, 0.57). fP < 0.05; OR = 0.02, 95% CI, (0.00, 0.19).212 S-Y Jiang et al
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highly proliferative potential. Therefore, mucus neck cells of the
body tissues or the regenerative gland cells of the antrum tissues
were chosen to compare to pre-neoplastic and cancer cells in levels
of RAR and RXR expression. Representative staining of the
tissues containing adjacent normal tissues as well as moderately
differentiated or well-differentiated adenocarcinoma is shown in
Figure 2 and Figure 3 respectively. In Figure 2, mucus neck cells in
the tissue expressed RARa with an intensity of ‘++’ (Figure 2A).
However, the adjacent cancer cells did not express RARa. RARb
was not expressed in either normal or cancer cells (Figure 2C).
RARg was expressed in both normal and cancer cells with an
intensity of ‘++’ (Figure 2E). RXRa and RXRb were expressed in
both normal and cancer cells with an intensity of ‘++++’ in the
adjacent tissues and ‘+++’ in the cancer tissues (Figure 2G, I).
Similarly, adjacent normal and cancer tissues from a specimen with
well-differentiated gastric adenocarcinoma were stained positive
for RARb, RARg, RXRa and RXRb mRNAs (Figure 3). RARa
mRNA was expressed in the adjacent normal tissue. However,
it was not expressed in the cancer tissues. Figure 4 shows the
representative RARa mRNA staining of the atrophic gastritis
tissue with the morphology of normal glands, intestinal metaplasia
and dysplasia. Expression of RARa was found only in adjacent
normal glands but not in intestinal metaplasia and dysplasia.
Table 2 summarizes the frequency of RAR and RXR mRNA
expression from eight cancer tissues. One cancer tissue was not
analysed due to a lack of adjacent non-malignant tissue. Mucus
neck cells from body tissues and regenerative gland cells from the
antrum tissues of normal individuals described above, and distal
normal tissues obtained from cancer patients, expressed all five
nuclear retinoid receptors (Table 2). In the cancer tissues, only two
among eight specimens stained positive for RARa mRNA.
Frequency of RARa expression in tissues with intestinal meta-
plasia, dysplasia or cancer was significantly lower than in the adja-
cent normal tissues (P < 0.05; Table 2). Loss of RARa expression
was correlated with an increase in the morphological features from
normal to cancer. Only one specimen did not have RARb expres-
sion in the adjacent normal tissues, intestinal metaplasia, dysplasia
and cancerous tissues. All eight cancer specimens with all histo-
logical features expressed RARg, RXRa and RXRb.
Expression of RARs and RXRs in adjacent normal
tissue, intestinal dysplasia and cancer lesions from the
same gastric cancer patient
The expression levels of RARs and RXRs in normal, premalignant
and malignant tissues within the same slide section are compared
(Table 3). Levels of RARa mRNA in adjacent normal, intestinal
metaplasia and dysplasia tissues were found to be higher than
those in cancer tissues in seven, two and two cases respectively.
Significantly more cases of adjacent normal tissues than intestinal
metaplasia and dysplasia had levels of RARa mRNA expression
higher than that of cancer cells (P < 0.05). No similar result was
found for the other four nuclear retinoid receptors. mRNA levels
of RARb and RXRa in adjacent normal, intestinal metaplasia and
dysplasia tissues were similar to cancer lesions in all cases. RARg
and RXRb mRNA expression in adjacent normal tissues in two
and three cases, respectively, was found to be greater than that in
cancer lesions. However, most intestinal metaplasia, dysplasia and
cancer lesions had similar levels of RaRg mRNA.
DISCUSSION
This study analysed in situ expression of nuclear retinoid receptors
in premalignant and malignant gastric tissues. Normal gastric
mucosa tissues expressed all five nuclear retinoid receptors, and
levels of RXRa mRNA were the highest among the five investi-
gated nuclear retinoid receptors in both normal gastric mucosa and
cancer tissues. No differences in expression of RARb, RARg,
RXRa and RXRb between normal tissues and cancer lesions were
observed. However, expression of RARa was significantly
decreased in intestinal metaplasia, dysplasia and cancer tissues.
Our data showed that tissues of normal gastric mucosa from the
body and antrum regions expressed both RAR and RXR. This
result suggests that the formation of a RAR/RXR heterodimer in
the presence of RA may play a physiological role in the growth and
differentiation of gastric mucosa. Alteration in levels of RA or
nuclear retinoid receptors may perturb cell growth or differentiation
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Figure 4 Detection of RARa mRNA in a non-malignant mucosa tissue from
the body region of a patient with well-differentiated gastric adenocarcinoma
in the antrum. The morphology of atrophic gastritis is shown by H&E staining
(bottom). Tissue sections were hybridized with antisense (A) or sense (B)
RARa probes. Normal glands (N), intestinal metaplasia (IM) or dysplasia (D)
tissues are indicated. Magnification ´ 200RAR and RXR expression in gastric tissues 213
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and may have an impact on gastric carcinogenesis. This is
supported by the finding that patients with gastric cancer have
lower levels of serum vitamin A than normal controls (Miasoedov
et al, 1989), and that individuals with low serum b-carotene levels
have an increased risk for the development of gastric cancer
(Haenszel et al, 1985). Among the five receptor subtypes, RXRa
mRNA appeared to express at the highest levels in various cell
types of gastric mucosa. RXR can regulate gene expression
through the formation of a RXR/RXR homodimer in response to
9-cis RA (Zhang et al, 1992). The receptor can also mediate signal
transduction of retinoids, thyroid hormone and vitamin D through
heterodimer formation between RXR and RAR, thyroid hormone
receptor or vitamin D receptor (Lablanc and Stunnenbery, 1995).
In addition, other receptors such as peroxisome proliferative acti-
vating receptor and orphan receptors are known to form
heterodimers with RXR. Due to generally higher levels of RXRa
expression than RAR in normal gastric mucosa, hormones such as
thyroid hormone or vitamin D may, therefore, also play a physio-
logical role in gastric mucosa.
The expression of RAR and RXR subtypes in normal and
cancer tissues has been investigated in various tissues. Expression
of RARa is decreased in tissues of squamous cell carcinoma
(Issing and Wustrow, 1996) and mouse skin tumours (Darwiche et
al, 1995, 1996), and the decrease is associated with activation of
the protein kinase C or H-ras oncogene in mouse skin tumours
(Darwiche et al, 1996). RARb expression is decreased in tissues of
the head and neck (Xu et al, 1994a), breast (Xu et al, 1997b;
Widschwendter et al, 1997), larynx (Castillo et al, 1997) and non-
small-cell lung cancers (Xu et al, 1997a). A decrease in RARg
expression is found in mouse skin tumours (Darwiche et al, 1995,
1996) and tissues of non-small-cell lung cancer (Xu et al, 1997b).
An increase in RXRa and a decrease in RXRb expression is found
in tumours of skin (Darwiche et al, 1995) and non-small-cell lung
cancer (Xu et al, 1997a) respectively. The difference in alteration
of RAR and RXR subtypes among various tumours may be associ-
ated with tissue-specific functions of each retinoid receptor
subtype as well as differences in mechanisms of carcinogenesis
among tumours. In this study, we only observed a significant
decrease in RARa expression in premalignant and malignant
gastric tissues among the five investigated nuclear retinoid recep-
tors. Mutation of K- and H-ras genes is detected, but uncommon,
in some cancer tissues and is rarely detected in precancerous
lesions (Soman et al, 1991; Tsuchiya et al, 1997). However, over-
expression of K- and H-ras proteins are observed much more
frequently in both premalignant and malignant gastric tissues
(Czerniak et al, 1989). It is therefore possible that the decrease in
RARa expression observed in gastric tissues may be related to the
activation of the ras oncogene as observed in mouse skin tumours
(Darwiche et al, 1996). However, ras mutation or overexpression
is preferentially associated with the development of the well-
differentiated type of gastric cancer (Tahara, 1993; Yoshida et al,
1988), which is inconsistent with the decrease in RARa expres-
sion in poorly differentiated gastric cancer with signet-ring cell
type, as observed in this study. It is therefore likely that other
genetic alterations, in addition to ras or PKC, may also contribute
to the abnormal RARa expression in gastric tissues.
Our study observed a decrease in RARa expression in both
premalignant and malignant gastric tissues. Similarly, a decrease
in RARa, RARb or RARg expression is observed in premalignant
tissues of the breast, oral, head and neck and skin (Xu et al, 1994a;
Darwiche et al, 1995, 1996; Lotan et al, 1995; Widschewendter et
al, 1997). Furthermore, McGregor et al (1997) have shown that the
loss of RARb expression occurs during the transition from senes-
cent to immortal phenotypes. These data suggest that the decrease
or loss of expression of nuclear retinoid receptors may occur
before neoplastic transformation. The alteration may be reversible.
Treatment with 13-cis retinoic acid can restore RARb expression
in premalignant oral tissues, and the restoration is correlated with a
clinical response (Lotan et al, 1995). Therefore, some of the
cancer-preventive activities of retinoids are mediated, first,
through restoring the expression of nuclear retinoid receptors and,
second, through bringing back the growth and differentiation
control by retinoids in precancerous lesions. N-4-hydroxyphenyl
retinamide has been found to prevent the progression of gastric
dysplasia into cancer (Han, 1993). Whether the effect is associated
with restoration of RARa expression requires further study.
During the process of gastric carcinogenesis, telomere reduction
leading to genomic instability appears to occur at the earliest step
(Tahara, 1993). Alterations in genes such as K- and H-ras, p53,
c-met and tpr-met occur later in precancerous lesions. Activation
of c-erbB and c-met oncogenes and loss of expression of genes
like cadherin, DCC, transforming growth factor b and type I
receptor of transforming growth factor b are involved in the later
stages of gastric cancer. We observed a decrease in RARa expres-
sion in intestinal metaplasia, dysplasia and cancer tissues.
Abnormality in expression of RARa appeared to occur at a similar
stage to that seen in genes such as K- and H-ras, p53, c-met and
trp-met. Currently, the possible link between these genes and RAR
has not been investigated and requires further study.
In summary, this study observed the expression of RAR and
RXR in normal gastric tissues, indicating the physiological func-
tion of RA on gastric mucosa. The decrease in expression of
RARa in premalignant and malignant gastric tissues suggests that
RARa has a significant role during processes of gastric carcino-
genesis. Investigating the mechanism of the loss of RARa expres-
sion may provide further insight regarding the mechanism of
growth control of gastric cancer cells.
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